200 related articles for article (PubMed ID: 30637797)
1. A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components.
Bofill Roig M; Gómez Melis G
Stat Med; 2019 May; 38(11):1935-1956. PubMed ID: 30637797
[TBL] [Abstract][Full Text] [Related]
2. Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.
Roig MB; Melis GG; Posch M; Koenig F
Biostatistics; 2023 Dec; 25(1):237-252. PubMed ID: 36150142
[TBL] [Abstract][Full Text] [Related]
3. A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints.
Sugimoto T; Sozu T; Hamasaki T; Evans SR
Biostatistics; 2013 Jul; 14(3):409-21. PubMed ID: 23307913
[TBL] [Abstract][Full Text] [Related]
4. Selection of composite binary endpoints in clinical trials.
Bofill Roig M; Gómez Melis G
Biom J; 2018 Mar; 60(2):246-261. PubMed ID: 29023990
[TBL] [Abstract][Full Text] [Related]
5. Multiplicity adjustment for composite binary endpoints.
Rauch G; Kieser M
Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a binary composite endpoint with missing data in components.
Quan H; Zhang D; Zhang J; Devlamynck L
Stat Med; 2007 Nov; 26(26):4703-18. PubMed ID: 17431851
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables.
Sozu T; Sugimoto T; Hamasaki T
Biom J; 2012 Sep; 54(5):716-29. PubMed ID: 22829198
[TBL] [Abstract][Full Text] [Related]
8. Blinded sample size recalculation in clinical trials with binary composite endpoints.
Sander A; Rauch G; Kieser M
J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous inference of a binary composite endpoint and its components.
Große Ruse M; Ritz C; Hothorn LA
J Biopharm Stat; 2017; 27(1):56-69. PubMed ID: 26881805
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of matched pair designs with two binary endpoints.
Jiang Y; Xu J
Stat Methods Med Res; 2017 Dec; 26(6):2526-2542. PubMed ID: 26294329
[TBL] [Abstract][Full Text] [Related]
11. Innovative Thinking on Endpoint Selection in Clinical Trials.
Chow SC; Huang Z
J Biopharm Stat; 2019; 29(5):941-951. PubMed ID: 31454270
[TBL] [Abstract][Full Text] [Related]
12. Gatekeeping testing via adaptive alpha allocation.
Li JD; Mehrotra DV
Biom J; 2008 Oct; 50(5):704-15. PubMed ID: 18932133
[TBL] [Abstract][Full Text] [Related]
13. Testing for qualitative heterogeneity: An application to composite endpoints in survival analysis.
Oulhaj A; El Ghouch A; Holman RR
Stat Methods Med Res; 2019 Jan; 28(1):151-169. PubMed ID: 28670972
[TBL] [Abstract][Full Text] [Related]
14. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
[TBL] [Abstract][Full Text] [Related]
15. Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.
Abel UR; Jensen K; Karapanagiotou-Schenkel I; Kieser M
J Biopharm Stat; 2015; 25(6):1285-311. PubMed ID: 25629760
[TBL] [Abstract][Full Text] [Related]
16. Methods for the analysis of multiple endpoints in small populations: A review.
Ristl R; Urach S; Rosenkranz G; Posch M
J Biopharm Stat; 2019; 29(1):1-29. PubMed ID: 29985752
[TBL] [Abstract][Full Text] [Related]
17. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.
Schüler S; Mucha A; Doherty P; Kieser M; Rauch G
Int J Cardiol; 2014 Jul; 175(1):126-32. PubMed ID: 24861257
[TBL] [Abstract][Full Text] [Related]
18. Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.
Sozu T; Sugimoto T; Hamasaki T
J Biopharm Stat; 2011 Jul; 21(4):650-68. PubMed ID: 21516562
[TBL] [Abstract][Full Text] [Related]
19. Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.
Zaslavsky BG
Pharm Stat; 2013; 12(4):207-12. PubMed ID: 23625660
[TBL] [Abstract][Full Text] [Related]
20. Testing multiple primary endpoints in clinical trials with sample size adaptation.
Liu Y; Hu M
Pharm Stat; 2016; 15(1):37-45. PubMed ID: 26607410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
